Titre :

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison.

Auteur(s) :

Penel, Nicolas [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Cantarel, Coralie [Auteur]
Bordeaux population health [BPH]
Institut Bergonié [Bordeaux]
Chemin-Airiau, Claire [Auteur]
Centre Léon Bérard [Lyon]
Ducimetiere, Françoise [Auteur]
Centre Léon Bérard [Lyon]
Gouin, François [Auteur]
Centre Léon Bérard [Lyon]
Le Loarer, François [Auteur]
Institut Bergonié [Bordeaux]
Toulmonde, Maud [Auteur]
Institut Bergonié [Bordeaux]
Piperno-Neumann, Sophie [Auteur]
Institut Curie [Paris]
Bellera, Carine [Auteur]
Bordeaux population health [BPH]
Institut Bergonié [Bordeaux]
Honore, Charles [Auteur]
Institut Gustave Roussy [IGR]
Blay, Jean-Yves [Auteur]
Centre Léon Bérard [Lyon]
Mathoulin-Pelissier, Simone [Auteur]
Bordeaux population health [BPH]
Institut Bergonié [Bordeaux]

Titre de la revue :

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

Nom court de la revue :

Ther Adv Med Oncol

Numéro :

15

Pagination :

17588359231192400

Date de publication :

2023-09-05

ISSN :

1758-8340

Mot(s)-clé(s) en anglais :

COVID-19 pandemic
delay
referral centers
resilience
sarcoma care pathway

Résumé en anglais : [en]

Background: The coronavirus disease 2019 (COVID-19) pandemic was an unprecedented shock to the healthcare systems, and its consequences on managing rare cancers are unknown. We investigated COVID-19’s impact on the activity ...
Lire la suite >Background: The coronavirus disease 2019 (COVID-19) pandemic was an unprecedented shock to the healthcare systems, and its consequences on managing rare cancers are unknown. We investigated COVID-19’s impact on the activity of sarcoma-labeled networks by comparing key indicators in 2019–2020 (before and during the pandemic, respectively). Methods: We compared the incidence of limb and trunk soft tissue sarcomas, surgery rate, surgery center, surgery quality, and surgery delays nationally and in various regions, focusing on the three most severely affected regions. Findings: In this study, sarcoma incidence did not decrease, and the tumor and patient characteristics were similar in both years. The number of patients who underwent surgery in the labeled centers increased significantly (63% versus 57%, p = 0.015), the rate of R0 resection increased (55% versus 47%, p = 0.004), and the rate of re-excision decreased (12% versus 21%, p < 0.0001). In the univariate analysis, the time to surgery was similar in both years. Cox regression analysis revealed that the factors associated with a longer time to surgery were age > 70 years (p = 0.003), retroperitoneal location (p > 0.001), tumor size (p < 0.001), deep tumors (p < 0.001), and regions (p < 0.001). However, we have observed an increase in the time before surgery in the regions most stroked by the COVID-19 pandemic. Interpretation: The model of the labeled center network for managing rare tumors was resilient. Paradoxically, the quality indicators improved during the pandemic due to the direct referral of patients with sarcomas to the labeled centers. Summary: This study shows that a nationwide network organization has made it possible to maintain care for these rare tumors during the pandemic.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Université de Lille
CHU Lille

Collections :

• METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Date de dépôt :

2024-01-20T22:08:53Z
2024-04-09T11:24:06Z